Intrinsic Value of S&P & Nasdaq Contact Us

Alignment Healthcare, Inc. ALHC NASDAQ

NASDAQ Global Select • Healthcare • Medical - Healthcare Plans • US • USD

SharesGrow Score
53/100
3/7 Pass
SharesGrow Intrinsic Value
$658.70
+2995.4%
Analyst Price Target
$24.50
+15.1%

Alignment Healthcare, Inc. (ALHC) generated $139.93M in operating cash flow for fiscal year 2025. After capital expenditures of $26.78M, free cash flow was $113.15M.

Free cash flow margin was 2.9% of revenue. Cash conversion ratio was -193.27x, suggesting some earnings are non-cash.

Criteria supported by this page:

  • HEALTH (33/100, Fail) — weak cash flow raises concerns about debt servicing
  • MOAT (42/100, Fail) — limited free cash flow weakens the competitive position
  • INCOME (30/100) — Cash conversion ratio was -193.27x suggests some earnings are non-cash items

Overall SharesGrow Score: 53/100 with 3/7 criteria passed.

SharesGrow 7-Criteria Score
53/100
SG Score
View full scorecard →
VALUE
75/100
Price-to-Earnings & upside
→ Valuation
FUTURE
88/100
Analyst consensus
→ Forecast
PAST
0/100
→ Income
HEALTH
33/100
Debt-to-Equity & liquidity
Proven by this page
MOAT
42/100
Proven by this page
GROWTH
100/100
→ Income
INCOME
30/100
→ Income
Alignment Healthcare, Inc. Cash Flow History
Metric TTM FY2025 FY2024 FY2023 FY2022
Operating Cash Flow $139.93M$139.93M$34.77M$-59.19M$-45.43M
Capital Expenditure $-8M$-26.78M$-41.42M$-36M$-23.77M
Free Cash Flow $123.67M$113.15M$-6.65M$-95.18M$-69.2M
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
Send us a message